AI assistant
Medtronic plc — Director's Dealing 2019
Oct 30, 2019
29841_dirs_2019-10-30_2c0ad24f-3f69-4a1b-9852-e2aa4aeef926.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Medtronic plc (MDT)
CIK: 0001613103
Period of Report: 2019-10-28
Reporting Person: Martha Geoffrey (EVP & GroupPres Restora Therap)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2019-10-28 | Ordinary Shares | A | 9729 | — | Acquired | 61536 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2019-10-28 | Stock Option (Right to Buy) | $106.22 | A | 65170 | Acquired | 2029-10-28 | Ordinary Shares (65170) | Direct |
Footnotes
F1: The restrictions on such restricted stock units shall lapse 100% on July 29, 2022 if the Company's cumulative non-GAAP diluted earnings per share growth during the 36 month period ending on the last day of the Company's fiscal year 2022 equals or exceeds a 3% cumulative compound annual growth rate, as determined by the Compensation Committee.
F2: This balance increased by 170 shares due to exempt transactions such as dividend reinvestment.
F3: These options become exercisable at the rate of 25% of the shares granted per year beginning on the first anniversary of grant.